Sterling Capital Management
SGP icon

Sterling Capital Management’s SpyGlass Pharma SGP Stock Holding History

Sterling Capital Management’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.92K Buy
266
+169
+174% +$4.16K ﹤0.01% 2706
2026
Q2 		$2.16K Buy
+97
New +$2.1K ﹤0.01% 2973

Other funds holding SGP

Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Sterling Capital Management's SGP Position: Q3 2026 in Review

Sterling Capital Management increased its SpyGlass Pharma (SGP) stake by 174% in Q3 2026, buying an estimated $4.16K and bringing the position to 266 shares worth $6.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

Sterling Capital Management first reported a position in SGP in Q2 2026 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Sterling Capital Management held 266 shares of SpyGlass Pharma worth $6.92K as of Q3 2026.
  • Sterling Capital Management bought 169 SpyGlass Pharma shares in Q3 2026, an estimated $4.16K.
  • SpyGlass Pharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2706 holding.
  • Sterling Capital Management first reported a position in SpyGlass Pharma in Q2 2026 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.